Universal CAR T cells produce rapid remissions and enable allogeneic stem cell transplants in patients with relapsed or refractory T-cell acute lymphoblastic leukemia.
Researchers at the University of Sharjah are exploring a promising approach that could enhance the immune system's ability to ...
After years of planning for cars that would let drivers take their hands off the wheel and eyes off the road, China’s regulators have become more cautious.
Chimeric antigen receptor T (CAR-T) cell therapy has revolutionized hematologic cancer treatment, but its efficacy in solid tumors remains limited by poor infiltration into the complex tumor ...
A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...
A research team at the Nano Life Science Institute (WPI-NanoLSI) and the Faculty of Medicine at Kanazawa University has ...
As the immune system weakens with age, researchers have found a way to temporarily boost its function by reprogramming liver cells to support T-cell development.
T-MAXIMUM is currently focused on late-stage malignant tumors, and its lead program for recurrent glioma has received clearance to enter Phase II clinical trials. Over the next three years, the ...
Humanity has sent into space everything from lightsabers and Tesla Roadsters to golden records and entire digital genetic ...
Cell phones and screens can help kids learn in school. In an increasingly technological world, prudent use of technology will ...
Bristol-Myers Squibb Company (NYSE: BMY) is one of the best stocks to buy for the next 5 years. On December 15, Goldman Sachs ...
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) (the 'Company”), a clinical-stage biotechnology company pioneering cell therapy for autoimmune diseases, today announced the appointment of Adrian Bot, M.D.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback